Longobardo V.,Kerr Drug Inc.
North Carolina medical journal | Year: 2013
This article provides an employer's perspective on the Patient Protection and Affordable Care Act of 2010. Since this act was implemented, it has significantly impacted how employers have been planning for and providing health insurance to their employees.
O'Connor S.K.,University of North Carolina at Chapel Hill |
O'Connor S.K.,Kerr Drug Inc. |
Ferreri S.P.,University of North Carolina at Chapel Hill |
Ferreri S.P.,Kerr Drug Inc. |
And 7 more authors.
Pharmacogenomics | Year: 2012
Aim: To describe the exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. An institutional review board-approved protocol for a clopidogrel pharmacogenetic program in a community pharmacy was developed to address feasibility and evaluate the pilot program. Study concept: Subjects taking clopidogrel are asked to participate at the point of medication dispensing. A pharmacist schedules an appointment with subjects to discuss the study and collects a buccal swab sample for CYP2C19 testing. When the results are available, the pharmacist consults with the subject's prescriber regarding test result interpretation and associated recommendations, and schedules a second appointment with the participant to discuss results and review any physician-approved therapeutic changes. The intervention-associated consultation is then billed to the subject's insurance. Results: Subject enrollment has begun. Conclusion: Community pharmacists may be valuable partners in pharmacogenetics. © 2012 Future Medicine Ltd.
General Electric and Kerr Drug Inc. | Date: 2001-02-27
newsletter containing health and wellness information which is distributed to members or potential members of a retail drug stores senior citizens purchasing incentive program.